Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening

Jiaqian Zhao; Yuqiao Liu; Ling Zhu; Junmin Li; Yanhui Liu; Jiarui Luo; Tian Xie; Dajing Chen

doi:10.1016/j.jpha.2023.04.015

Volume 13 Issue 6

Jun. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2023 > 13(6): 673-682

Jiaqian Zhao, Yuqiao Liu, Ling Zhu, Junmin Li, Yanhui Liu, Jiarui Luo, Tian Xie, Dajing Chen. Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening[J]. Journal of Pharmaceutical Analysis, 2023, 13(6): 673-682. doi: 10.1016/j.jpha.2023.04.015

Citation:

Jiaqian Zhao, Yuqiao Liu, Ling Zhu, Junmin Li, Yanhui Liu, Jiarui Luo, Tian Xie, Dajing Chen. Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening[J]. Journal of Pharmaceutical Analysis, 2023, 13(6): 673-682. doi: 10.1016/j.jpha.2023.04.015

Citation:

Jiaqian Zhao, Yuqiao Liu, Ling Zhu, Junmin Li, Yanhui Liu, Jiarui Luo, Tian Xie, Dajing Chen. Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening[J]. Journal of Pharmaceutical Analysis, 2023, 13(6): 673-682. doi: 10.1016/j.jpha.2023.04.015

PDF( 3674 KB)

Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening

doi: 10.1016/j.jpha.2023.04.015

Jiaqian Zhao^a,b,
Yuqiao Liu^a,
Ling Zhu^a,
Junmin Li^a,
Yanhui Liu^a,
Jiarui Luo^a,
Tian Xie^{a,b
,
,},
Dajing Chen^{a
,
,}

a. School of Pharmacy, Hangzhou Normal University, Hangzhou, 310000, China;
b. Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China

Funds:

This work was supported by the National Natural Science Foundation of China, China (Grant Nos.: 61801160 and 81730108).

Received Date: Dec. 13, 2022
Accepted Date: Apr. 22, 2023
Rev Recd Date: Apr. 19, 2023
Publish Date: Apr. 26, 2023

Abstract

Abstract

Glucose transporter 1 (GLUT1) overexpression in tumor cells is a potential target for drug therapy, but few studies have reported screening GLUT1 inhibitors from natural or synthetic compounds. With current analysis techniques, it is difficult to accurately monitor the GLUT1 inhibitory effect of drug molecules in real-time. We developed a cell membrane-based glucose sensor (CMGS) that integrated a hydrogel electrode with tumor cell membranes to monitor GLUT1 transmembrane transport and screen for GLUT1 inhibitors in traditional Chinese medicines (TCMs). CMGS is compatible with cell membranes of various origins, including different types of tumors and cell lines with GLUT1 expression knocked down by small interfering RNA or small molecules. Based on CMGS continuous monitoring technique, we investigated the glucose transport kinetics of cell membranes with varying levels of GLUT1 expression. We used CMGS to determine the GLUT1-inhibitory effects of drug monomers with similar structures from Scutellaria baicalensis and catechins families. Results were consistent with those of the cellular glucose uptake test and molecular-docking simulation. CMGS could accurately screen drug molecules in TCMs that inhibit GLUT1, providing a new strategy for studying transmembrane protein-receptor interactions.
- Glucose transporter 1 inhibitor,
- Electrochemical sensor,
- Drug screen,
- Traditional Chinese medicine

FullText(HTML)

References(39)

References

K.J. Na, H. Choi, H.R. Oh, et al., Reciprocal change in Glucose metabolism of Cancer and Immune cells mediated by different Glucose Transporters predicts Immunotherapy response, Theranostics 10 (2020) 9579-9590.

X. Jiang, J. Wu, M. Ke, et al., Engineered XylE as a tool for mechanistic investigation and ligand discovery of the glucose transporters GLUTs, Cell. Discov. 5 (2019), 14.

L. Sylow, M. Kleinert, E.A. Richter, et al., Exercise-stimulated glucose uptake-regulation and implications for glycaemic control, Nat. Rev. Endocrinol. 13 (2017) 133-148.

T.M. Cheng, H.L. Chu, Y. Lee, et al., Quantitative analysis of glucose metabolic cleavage in glucose transporters overexpressed cancer cells by target-specific fluorescent gold nanoclusters, Anal. Chem. 90 (2018) 3974-3980.

Y. Wang, J. Li, Z. Chen, et al., A GLUTs/GSH cascade targeting-responsive bioprobe for the detection of circulating tumor cells, Chem. Commun (Camb). 58 (2022) 3945-3948.

S. Wu, K. Zhang, Y. Liang, et al., Nano-enabled tumor systematic energy exhaustion via Zinc (II) interference mediated glycolysis inhibition and specific GLUT1 depletion, Adv. Sci. (Weinh) 9 (2022), e2103534.

A. Zaritski, H. Castillo-Ecija, M. Kumarasamy, et al., Selective accumulation of galactomannan amphiphilic nanomaterials in pediatric solid tumor xenografts correlates with GLUT1 gene expression, ACS Appl. Mater. Interfaces 11 (2019) 38483-38496.

Y.Y. Song, Y. Yuan, X. Shi, et al., Improved drug delivery and anti-tumor efficacy of combinatorial liposomal formulation of genistein and plumbagin by targeting Glut1 and Akt3 proteins in mice bearing prostate tumor, Colloids Surf. B Biointerfaces 190 (2020), 110966.

W. Jiang, X. Luo, L. Wei, et al., The sustainability of energy conversion inhibition for tumor ferroptosis therapy and chemotherapy, Small 17 (2021), e2102695.

A.R. Guerra, M.F. Duarte, I.F. Duarte, Targeting tumor metabolism with plant-derived natural products: emerging trends in cancer therapy, J. Agric. Food Chem. 66 (2018) 10663-10685.

J.W. Jang, H. Kim, I. Kim, et al., Surface functionalization of enzyme-coronated gold nanoparticles with an erythrocyte membrane for highly selective glucose assays, Anal. Chem. 94 (2022) 6473-6481.

R. Singh, S. Kumar, F. Liu, et al., Etched multicore fiber sensor using copper oxide and gold nanoparticles decorated graphene oxide structure for cancer cells detection, Biosens. Bioelectron. 168 (2020), 112557.

N. Wang, S. Zhang, Y. Yuan, et al., Molecular basis for inhibiting human glucose transporters by exofacial inhibitors, Nat. Commun. 13 (2022), 2632.

F. Shao, Y. Wu, Z. Tian, et al., Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy, Biomaterials 274 (2021), 120869.

J. Hong, M. Kang, M. Jung, et al., T-cell-derived nanovesicles for cancer immunotherapy, Adv. Mater. 33 (2021), e2101110.

X. Liu, X. Gao, L. Yang, et al., Metal-organic framework-functionalized paper-based electrochemical biosensor for ultrasensitive exosome assay, Anal. Chem. 93 (2021) 11792-11799.

J. Chang, H. Li, T. Hou, et al., Paper-based fluorescent sensor via aggregation induced emission fluorogen for facile and sensitive visual detection of hydrogen peroxide and glucose, Biosens. Bioelectron. 104 (2018) 152-157.

C. Gu, X. Kong, X. Liu, et al., Enzymatic biofuel-cell-based self-powered biosensor integrated with DNA amplification strategy for ultrasensitive detection of single-nucleotide polymorphism, Anal. Chem. 91 (2019) 8697-8704.

H. Wu, C. Shi, Q. Zhu, et al., Capillary-driven blood separation and in situ electrochemical detection based on 3D conductive gradient hollow fiber membrane, Biosens. Bioelectron. 171 (2021), 112722.

I. Kim, D. Kwon, D. Lee, et al., A highly permselective electrochemical glucose sensor using red blood cell membrane, Biosens. Bioelectron. 02 (2018) 617-623.

I. Kim, D. Kwon, D. Lee, et al., Permselective glucose sensing with GLUT1-rich cancer cell membranes, Biosens. Bioelectron. 135 (2019) 82-87.

J. Zhao, C. Wang, X. Zhang, et al., Cell membrane coated electrochemical sensor for kinetic measurements of GLUT transport, Anal. Chimica Acta 1226 (2022), 340263.

Y. Luo, J. Zhao, X. Zhang, et al., Size controlled fabrication of enzyme encapsulated amorphous calcium phosphate nanoparticle and its intracellular biosensing application, Colloids Surf. B Biointerfaces 201 (2021), 111638.

S.H. Huang, B.C. Huang, L. Chao, Development of cell membrane electrophoresis to measure the diffusivity of a native transmembrane protein, Anal. Chem. 94 (2022) 4531-4537.

L. Li, L. Li, W. Li, et al., TAp73-induced phosphofructokinase-1 transcription promotes the Warburg effect and enhances cell proliferation, Nat. Commun. 9 (2018), 4683.

Y.M. Lee, G. Lee, T.I. Oh, et al., Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress, Int. J. Oncol. 48 (2016) 399-408.

X. Chen, J. Tan, L. Zhang, et al., Apigenin ameliorates vascular injury in rats with high fructose-induced metabolic disturbance by inhibiting PI3K/AKT/GLUT1, RSC Adv. 8 (2018) 24470-24476.

S.Y. Lee, J.H. Park, S.H. Ko, et al., Mussel-inspired hyaluronic acid derivative nanostructures for improved tumor targeting and penetration, ACS Appl. Mater. Interfaces 9 (2017) 22308-22320.

P.M. Ung, W. Song, L. Cheng, et al., Inhibitor discovery for the human GLUT1 from homology modeling and virtual screening, ACS Chem. Biol. 11 (2016) 1908-1916.

R. Commander, C. Wei, A. Sharma, et al., Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion, Nat. Commun. 11 (2020), 1533.

J. Liu, C. Zhang, R. Wu, et al., RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling, Oncotarget 6 (2015), 14982-14992.

N. Kong, X. Chen, J. Feng, et al., Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1, Acta Pharm. Sin. B 11 (2021) 4045-4054.

P. Fang, M. Yu, L. Zhang, et al., Baicalin against obesity and insulin resistance through activation of AKT/AS160/GLUT4 pathway, Mol. Cell. Endocrinol. 448 (2017) 77-86.

R. Wu, K. Zhu, X. Zhang, et al., Nonimmobilized biomaterial capillary electrophoresis for screening drugs targeting human glucose transporter 1, Anal. Chem. 89 (2017) 12951-12959.

D. Deng, C. Xu, P. Sun, et al., Crystal structure of the human glucose transporter GLUT1, Nature 510 (2014) 121-125.

O.A. Ojelabi, K.P. Lloyd, J.K. De Zutter, et al., Red wine and green tea flavonoids are cis-allosteric activators and competitive inhibitors of glucose transporter 1 (GLUT1)-mediated sugar uptake, J. Biol. Chem. 293 (2018) 19823-19834.

J.J. Gu, K.S. Qiao, P. Sun, et al., Study of EGCG induced apoptosis in lung cancer cells by inhibiting PI3K/Akt signaling pathway, Eur. Rev. Med. Pharmacol. Sci. 22 (2018) 4557-4563.

Q. Wu, B. Zhao, G. Sui, et al., Phytochemicals block glucose utilization and lipid synthesis to counteract metabolic reprogramming in cancer cells, Appl. Sci. 11 (2021), 1259.

I. Peluso, M. Serafini, Antioxidants from black and green tea: from dietary modulation of oxidative stress to pharmacological mechanisms, Br. J. Pharmacol. 174 (2017) 1195-1208.

Relative Articles

Supplements(0)

Cited By

Proportional views